Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy
MedComm (2020)
.
2025 Jan 3;6(1):e70022.
doi: 10.1002/mco2.70022.
eCollection 2025 Jan.
Authors
Ram Abou Zaki
1
2
,
Assam El-Osta
1
3
Affiliations
1
Epigenetics in Human Health and Disease Program Baker Heart and Diabetes Institute Melbourne Victoria Australia.
2
Baker Department of Cardiometabolic Health The University of Melbourne Parkville Australia.
3
Department of Medicine and Therapeutics The Chinese University of Hong Kong (CUHK) Hong Kong SAR China.
PMID:
39764558
PMCID:
PMC11702423
DOI:
10.1002/mco2.70022
No abstract available